Literature DB >> 15668947

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for quantitation and molecular stability assessment of insulin entrapped within PLGA nanoparticles.

Ugo Bilati1, Carla Pasquarello, Garry L Corthals, Denis F Hochstrasser, Eric Allémann, Eric Doelker.   

Abstract

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) was evaluated for both qualitative and quantitative analysis of insulin entrapped within poly(D,L-lactic-co-glycolic acid) nanoparticles. Quantitation was performed by adding an internal standard (arg-insulin) to defined and unknown sample solutions, in order to reduce point-to-point and sample-to-sample variability. The ratio of the peak height of insulin to the peak height of arg-insulin was plotted against the insulin concentration. In this way, an excellent linear relationship was found (R2 > 0.99). This method of quantitation was compared with classical UV spectroscopy and reverse-phase high-performance liquid chromatography measurements. All methods provided close final drug loading values for the insulin-loaded nanoparticle batches tested. Additionally, with respect to molecular stability, covalent insulin dimers were found only at trace levels in those nanoparticles. Compared with other methods, MALDI-TOF MS is a valuable tool for the characterization of proteins from nanoparticles, because no extensive extraction and complex sampling procedures are required. Copyright 2005 Wiley-Liss, Inc. and the American Pharmacists Association.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668947     DOI: 10.1002/jps.20266

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  1 in total

1.  Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues.

Authors:  Ugo Bilati; Eric Allémann; Eric Doelker
Journal:  AAPS PharmSciTech       Date:  2005-12-01       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.